Publications

IEDB-3D 2.0: Structural data analysis within the Immune Epitope Database

Mendes M, Mahita J, Blazeska N, Greenbaum J, Ha B, Wheeler K, Wang J, Shackelford D, Sette A, Peters B

Coronavirus Immunotherapeutic Consortium Database.

Mahita J, Ha B, Gambiez A, Schendel SL, Li H, Hastie KM, Dennison SM, Li K, Kuzmina N, Periasamy S, Bukreyev A, Munt JE, Osei-Twum M, Atyeo C, Overton JA, Vita R, Guzman-Orozco H, Mendes M, Kojima M, Halfmann PJ, Kawaoka Y, Alter G, Gagnon L, Baric RS, Tomaras GD, Germann T, Bedinger D, Greenbaum JA, Saphire EO, Peters B

Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria

Belmonte M, Ganeshan H, Huang J, Belmonte A, Inoue S, Velasco R, Acheampong N, Ofori EA, Akyea-Mensah K, Frimpong A, Ennuson NA, Frempong AF, Kyei-Baafour E, Amoah LE, Edgel K, Peters B, Villasante E, Kusi KA, Sedegah M

Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria

Belmonte M, Ganeshan H, Huang J, Belmonte A, Inoue S, Velasco R, Acheampong N, Ofori EA, Akyea-Mensah K, Frimpong A, Ennuson NA, Frempong AF, Kyei-Baafour E, Amoah LE, Edgel K, Peters B, Villasante E, Kusi KA, Sedegah M

Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile

Chihab LY, Kuan R, Phillips EJ, Mallal SA, Rozot V, Davis MM, Scriba TJ, Sette A, Peters B, Lindestam Arlehamn CS; SATVI Study Group

Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile

Chihab LY, Kuan R, Phillips EJ, Mallal SA, Rozot V, Davis MM, Scriba TJ, Sette A, Peters B, Lindestam Arlehamn CS; SATVI Study Group

Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells

Brightman SE, Naradikian MS, Thota RR, Becker A, Montero L, Bahmanof M, Premlal ALR, Greenbaum JA, Peters B, Cohen EE, Miller AM, Schoenberger SP

Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells

Brightman SE, Naradikian MS, Thota RR, Becker A, Montero L, Bahmanof M, Premlal ALR, Greenbaum JA, Peters B, Cohen EE, Miller AM, Schoenberger SP

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

Callaway HM, Hastie KM, Schendel SL, Li H, Yu X, Shek J, Buck T, Hui S, Bedinger D, Troup C, Dennison SM, Li K, Alpert MD, Bailey CC, Benzeno S, Bonnevier JL, Chen JQ, Chen C, Cho H, Crompton PD, Dussupt V, Entzminger KC, Ezzyat Y, Fleming JK, Geukens N, Gilbert AE, Guan Y, Han X, Harvey CJ, Hatler JM, Howie B, Hu C, Huang A, Imbrechts M, Jin A, Kamachi N, Keitany G, Klinger M, Kolls JK, Krebs SJ, Li T, Luo F, Maruyama T, Meehl MA, Mendez-Rivera L, Musa A, Okumura CJ, Rubin BER, Sato AK, Shen M, Singh A, Song S, Tan J, Trimarchi JM, Upadhyay DP, Wang Y, Yu L, Yuan TZ, Yusko E, Peters B, Tomaras G, Saphire EO